Today: 13 December 2025
Subscribe
Browse Tag

JNJ

Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025)

Johnson & Johnson Stock (JNJ) Jumps Near 52-Week Highs on FDA Approval and Oncology Data — Week in Review, Week Ahead (Updated Dec. 12, 2025)

(SEO): Johnson & Johnson (NYSE: JNJ) climbed to $211.58 this week as investors weighed FDA approval news, breakthrough oncology data, and fresh talc-trial risk. Reuters+3Investing.com+3JNJ.com+3 Johnson & Johnson stock (NYSE: JNJ) capped a volatile but decisively positive week by closing
13 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson (JNJ) Stock Hits New High After the Bell on December 11, 2025 – What to Know Before the December 12 Open

Johnson & Johnson (JNJ) Stock Hits New High After the Bell on December 11, 2025 – What to Know Before the December 12 Open

Johnson & Johnson (NYSE: JNJ) closed regular trading on Thursday, December 11, 2025 at $210.01, up about 1.7% on the day, marking a fresh 52‑week high before easing slightly in after‑hours trading around $209.25. MarketScreener+1 That move capped a week
12 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson (JNJ) Stock on December 10, 2025: Pipeline Breakthroughs, Talc Risks and What Analysts Expect Next

Johnson & Johnson (JNJ) Stock on December 10, 2025: Pipeline Breakthroughs, Talc Risks and What Analysts Expect Next

Updated: December 10, 2025 Johnson & Johnson (NYSE: JNJ) is trading near fresh highs as investors weigh powerful growth drivers in oncology and immunology against a still‑messy overhang from talc litigation. As of late trading on December 10, 2025, JNJ
10 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson (JNJ) Stock on December 6, 2025: Price, Latest News, Analyst Targets and Dividend Outlook

Johnson & Johnson (JNJ) Stock on December 6, 2025: Price, Latest News, Analyst Targets and Dividend Outlook

Johnson & Johnson (NYSE: JNJ) heads into December 2025 as one of the market’s standout large‑cap healthcare performers, combining a 2025 share‑price surge with classic “defensive” traits like steady earnings and a long dividend track record—while still carrying a very
6 December 2025
 ·  ·  ·  ·  · 
Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (NYSE: JNJ) is trading around $205–$206 per share on Wednesday, December 3, 2025, just shy of its 52‑week high of about $207.81, after a powerful rally that has lifted the stock roughly 40% this year. MarketBeat+2ChartMill+2 Today’s
4 December 2025
 ·  ·  ·  ·  · 
Go toTop